{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:35:17Z","timestamp":1790012117146,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T00:00:00Z","timestamp":1726963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024744","name":"Snow Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023410","name":"Snow Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2022557"],"award-info":[{"award-number":["APP2022557"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1173163"],"award-info":[{"award-number":["APP1173163"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jinf.2024.106286","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:27:44Z","timestamp":1727353664000},"page":"106286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-&lt;70 years old"],"prefix":"10.1016","volume":"89","author":[{"given":"C.","family":"McLeod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dymock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Plebanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Tjiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.C.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.L.","family":"Mordant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Wadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mckenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.L.","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.106286_bib1","unstructured":"World Health Organization. Guidance on developing national COVID-19 vaccination policy and integrating COVID-19 vaccination into national immunization programmes and broader health care delivery mechanisms in the WHO European Region Copenhagen: WHO Regional Office for Europe; 2023, \/\/iris.who.int\/bitstream.handle\/10665.372137\/WHO-EURO-2023-7892-47660-70230-eng.pdf?sequence=1, accessed on 7.7.2024."},{"key":"10.1016\/j.jinf.2024.106286_bib2","unstructured":"Welfare AIoHa. The impact of a new disease: COVID-19 from 2020, 2021 and into 2022. In: Welfare Ha, editor. Department of Health; 2022, www.aihw.gov.au\/getmedia\/c017fa79-be4b-4ad5-bbf3-2878ed0995e5\/aihw-aus-240_chapter_1.pdf.aspx, accessed on 5.7.24."},{"issue":"13","key":"10.1016\/j.jinf.2024.106286_bib3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.jinf.2024.106286_bib4","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1016\/j.vaccine.2023.06.005","article-title":"Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021\u2013January 2022","volume":"41","author":"de Gier","year":"2023","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jinf.2024.106286_bib5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2024.106286_bib6","unstructured":"(ATAGI) ATAGoI. ATAGI: COVID-19 vaccination updates; 2022. \u3008https:\/\/www.health.gov.au\/committees-and-groups\/australian-technical-advisory-group-on-immunisation-atagi#weekly-covid19-meeting-updates\u3009."},{"issue":"1","key":"10.1016\/j.jinf.2024.106286_bib7","first-page":"202","article-title":"Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)","volume":"24","author":"McLeod","year":"2023","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106286_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13063-024-08343-y","article-title":"Statistical considerations for the Platform Trial in COVID-19 vaccine priming and boosting","volume":"25","author":"Dymock","year":"2024","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.jinf.2024.106286_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"Munro","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106286_bib10","unstructured":"Group IEW. Addenum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials E9(R1); 2019. \u3008https:\/\/database.ich.org\/sites\/default\/files\/E9-R1_Step4_Guideline_2019_1203.pdf\u3009 (accessed 20.12.2023)."},{"key":"10.1016\/j.jinf.2024.106286_bib11","unstructured":"Team SD Stan Modeling Language Users Guide Reference Manual, 2.34; 2024, http:\/\/mc-stan.org, accessed on 4.6.2024."},{"key":"10.1016\/j.jinf.2024.106286_bib12","unstructured":"Gabry JCR, Johnson A. cmdstanr: R Interface to \u2018CmdStan\u2019; 2022, http:\/\/mc-stan.org\/cmdstanr, accessed on 10.06.2024."},{"key":"10.1016\/j.jinf.2024.106286_bib13","unstructured":"Team RC. A language and environment for statistical computing, R foundation for statistical computing; 2022, http:\/\/www.R-project.org\/, accessed on 02.06.2024."},{"key":"10.1016\/j.jinf.2024.106286_bib14","unstructured":"Network TAC-S. Seroprevalence of SARS-CoV-2-specific antibodies among Australian blood donors, February\u2013March 2022. In: Institute K, editor; 2022, http:\/\/www.kirby.unsw.edu.au\/sites\/default\/files\/documents\/COVID-19-Blood-Donor-Report-Round1-Feb-Mar-2022%5B1%5D.pdf, accessed on 20.06.2024."},{"key":"10.1016\/j.jinf.2024.106286_bib15","unstructured":"Network AC-S. Seroprevalence of SARS-CoV-2-specific antibodies among Australian blood donors: round 3 update; 2023. Kirby Institute, http:\/\/www.kirby.unsw.edu.au\/sites\/default\/files\/documents\/COVID-19-Blood-Donor-Report-Round3-Aus-Sept-2022%5B1%5D.pdf, accessed on 4.06.2024."},{"issue":"7","key":"10.1016\/j.jinf.2024.106286_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2024.02.021","article-title":"Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: a population-based observational study","volume":"42","author":"Kim","year":"2024","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jinf.2024.106286_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2213-2600(22)00059-5","article-title":"Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis","volume":"10","author":"Ling","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.jinf.2024.106286_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2024.106286_bib19","article-title":"XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants","author":"Wang","year":"2023","journal-title":"Cold Spring Harbour"},{"issue":"16","key":"10.1016\/j.jinf.2024.106286_bib20","doi-asserted-by":"crossref","first-page":"10400","DOI":"10.3390\/ijerph191610400","article-title":"Public health management of the COVID-19 pandemic in Australia: the role of the Morrison Government","volume":"19","author":"Duckett","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"10.1016\/j.jinf.2024.106286_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1473-3099(22)00376-0","article-title":"FIND documents dramatic reduction in COVID-19 testing","volume":"22","author":"Usher","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106286_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.csda.2019.106901","article-title":"Borrowing strength and borrowing index for Bayesian hierarchical models","volume":"144","author":"Xu","year":"2020","journal-title":"Comput Stat Data Anal"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324002202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324002202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:59:55Z","timestamp":1778669995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324002202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0163445324002202"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106286","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106286"}}